For example, the GEMM‐ESC strategy was used to introduce the Met proto‐oncogene in a GEMM of BRCA1‐associated breast cancer, which yielded a novel mouse model of BRCA1‐deficient metaplastic breast cancer (Henneman et al, 2015). The gene discussed is BRCA1; the disease is breast cancer.